Two clinics buy the same refurbished therapy unit from two different vendors at the same price. One has the service history, the calibration record and a named engineer; the other has a photograph and an invoice. Eighteen months later the difference is not the price they paid but whether the device was working, and by then the vendor selection decision has already been made.
Last updated:
What vendor selection is actually deciding
Choosing a medical equipment vendor determines cost efficiency, patient safety and long-term operational success, and those three pull in different directions. A vendor who is cheapest on unit price is often the one with no service capacity; a vendor with deep service capacity is rarely the cheapest.
The selection problem is sharper than it used to be. Inflated prices, counterfeit supplies, inconsistent quality and long lead times are all live risks, and the secondary market for refurbished devices has grown faster than most clinics’ ability to validate what is being sold. Only a fraction of clinics hold the technical resources to check a device before purchase, which is precisely the gap a documented evaluation process closes.
Why the traditional route under-delivers
Traditional selection leans on personal networks, trade events and unverified listings. That produces four structural weaknesses rather than occasional mistakes.
The first is transparency: buyers often cannot confirm device history, service records or warranty validity. The second is transaction risk, because weak verification mechanisms make scams and substandard equipment more common than the sector admits. The third is time, since manual comparison and quoting across vendors runs on email. The fourth is reputation, because there is usually no centralised record of how a vendor has performed before.
None of those is solved by a better conversation. They are solved by deciding in advance what evidence a vendor must produce.
The trade-off, stated plainly
Every vendor evaluation is a trade between five variables, and a scorecard is simply the discipline of deciding the weights before the quotations arrive.
| Variable | What good looks like | What it costs you when it is missing |
|---|---|---|
| Regulatory evidence | Model verifiable in the premarket record; UDI resolvable | A device that cannot be placed into service |
| Condition record | Service history against a stated specification | Unexplained failures attributed to the device class |
| Service capability | Named engineers, response times, spare parts | Downtime measured in weeks rather than days |
| Commercial terms | Warranty, upgrade rights, exit clause | A price advantage that cannot be repeated |
| Supply stability | Lead times, warehouse capacity, contingency plan | An order that arrives after the clinical need |
Regulatory evidence sits first because it is the only variable that cannot be compensated for later. Everything else can be mitigated with money or time; a device without a verifiable record cannot be mitigated at all.
How to verify a vendor’s compliance claim
The claim is checkable, and the checks are public. The FDA’s classification guidance establishes the device class and the premarket route the manufacturer had to take; Devices@FDA searches 510(k) notifications and premarket approvals together, so a model can be matched against the submission that names it; and the UDI System identifies devices from manufacturing through distribution to patient use, with the identifier resolving in AccessGUDID.
Serial-level records are the practical form of that check, and they are worth understanding before the first quotation arrives: serial number traceability for medical equipment sets out what a vendor should be able to produce for an individual unit.
Post-market status is the fourth check: correction and removal actions are published in the FDA’s recall and early-alert database, and a vendor who cannot produce a dated statement of recall status for the specific model has not verified anything.
For refurbished equipment there is a fifth question, and it is the one most often left unasked. The FDA’s Remanufacturing of Medical Devices guidance, finalised in May 2024, distinguishes servicing — returning a device to the specification it was cleared with — from remanufacturing, which changes the device’s performance, safety characteristics or intended use and shifts the regulatory obligations onto the entity that performed the work. Ask which applies and against which specification the work was done; the answer separates a vendor from a broker.
Destination adds a sixth. For a device entering Great Britain, the MHRA’s requirements for registrations, a UK responsible person, UKCA marking and post-market surveillance sit alongside the FDA record rather than replacing it, so a vendor serving both markets should be able to describe both files.
A vendor scorecard, with weights you can argue with
This is a model with stated assumptions, not a measurement. The weights are an example; the point is that they are set before quotations arrive, not after.
Take a INDIBA CT8/CT9 therapy unit listed at $16,000 and imagine two vendors quoting it. Score each on a 1–5 scale against weights of 30% regulatory evidence, 25% service capability, 20% condition record, 15% commercial terms and 10% supply stability.
Vendor A quotes $16,000 with full records, a named engineer and a two-year warranty; scores 5/5/4/4/4, a weighted 4.35. Vendor B quotes $14,400 — ten percent cheaper — with no service history beyond a photograph and no engineer named; scores 3/2/2/3/3, a weighted 2.60.
The $1,600 saving is now visibly priced against a service capability the clinic would have to buy elsewhere. Change one weight — if service capability is worth 40% instead of 25%, Vendor B falls further and the decision becomes unambiguous rather than marginal.
What to ask, and what to put in the contract
Before signing, ask for the premarket reference for the model, a dated recall statement, the service and calibration history against a stated specification, the sterilization or reprocessing instructions where the device is reusable, spare parts availability, and the qualifications of the technicians who will attend.
In the contract, define measurable key performance indicators, performance-based payment terms, warranty coverage, penalty clauses for non-performance, upgrade rights and compliance responsibilities. Include the exit terms. A vendor relationship is best judged on the terms that apply when it ends.
After-sales deserves its own column in the evaluation rather than a footnote. Check the service level agreement, response-time guarantees, the preventive maintenance plan, technician qualifications, spare parts inventory and training support — and ask for a documented escalation path, because the escalation path is what a clinical director will need at 2am.

References
- FDA: Classify Your Medical Device — the three classes and the premarket route each implies.
- FDA: Medical Device Databases — Devices@FDA (510(k) and PMA) and quarterly registration and listing.
- FDA: Unique Device Identification System (UDI System).
- FDA: Medical Device Recalls and Early Alerts.
- GOV.UK / MHRA: Regulating medical devices in the UK.
Set the weights before the quotes arrive. Listings carry the model, the condition and the seller, so the verification checks can run before a vendor is shortlisted.
FAQ
What is the single most useful question to ask a vendor?
Whether the work performed on a refurbished device was servicing or remanufacturing, and against which specification. Servicing returns a device to its cleared specification; remanufacturing changes its performance, safety characteristics or intended use and moves the regulatory duties to whoever did the work.
How do I check a vendor’s compliance claim without being an expert?
Ask for the submission reference and match the model in Devices@FDA, resolve the UDI in AccessGUDID, and request a dated statement of recall status. Those three are public records, and a vendor who cannot supply the references is telling you something.
Is the cheapest quotation ever the right choice?
Sometimes, when everything else in the scorecard is equal. In the model above the cheaper vendor scored 2.60 against 4.35, which prices the $1,600 saving against a service capability the clinic would have to buy separately. Weight the variables first and the answer usually stops being marginal.
What after-sales terms should be non-negotiable?
A defined response time, a preventive maintenance plan, named or qualified technicians, spare parts availability and a documented escalation path. Add training support if the device requires operator competency, and record all of it in the contract rather than in an email.
How do I judge a vendor’s supply stability?
Ask for lead times, warehouse or distribution capacity, backorder rates and the contingency plan for a missed shipment. A vendor who can describe what happens when a delivery fails is more useful than one who promises it never will.
Part of the Sourcing Medical Equipment by Type guide.



